DE-104 ophthalmic solution

DE-104 · Santen Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for DE-104 ophthalmic solution, covering 2009-03-16 to 2011-11-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension [Phase 2]

See pricing